Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;13(10):991-6.
doi: 10.1089/dia.2011.0046. Epub 2011 Jul 19.

Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study

Ticiana C Rodrigues  1 , Adrienne M Veyna, Michelle D Haarhues, Gregory L Kinney, Marian Rewers, Janet K Snell-Bergeon
Affiliations

Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study

Ticiana C Rodrigues et al. Diabetes Technol Ther. 2011 Oct.

Abstract

Background: The aim was to examine whether excess weight is associated with coronary artery calcium (CAC), independent of metabolic parameters in adults with type 1 diabetes (T1D).

Methods: Subjects between 19 and 56 years of age with T1D (n=621) from the Coronary Artery Calcification in Type 1 Diabetes study were classified as abnormal on four metabolic parameters: blood pressure ≥130/85 mm Hg or on antihypertensive treatment; high-density lipoprotein-cholesterol of <40 mg/dL for men or <50 mg/dL for women; triglycerides of ≥150 mg/dL; or C-reactive protein of ≥3 μg/mL. Study participants with two or more abnormal parameters were classified as metabolically abnormal. Weight categories by body mass index were normal (<25 kg/m(2)), overweight (25 to <30 kg/m(2)), and obese (≥30 kg/m(2)). CAC was measured at two visits 6.0±0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥2.5 mm(3) or development of clinical coronary artery disease.

Results: Among subjects with T1D, 48% of normal, 61% of overweight, and 73% of obese participants were classified as metabolically abnormal (P<0.0001). Overweight and obesity were independently associated with presence of CAC, independent of presence of metabolically abnormal. Obesity but not overweight was associated with CAC progression, independent of the other cardiovascular risk factors.

Conclusions: Although obesity is known to increase cardiovascular disease risk through inducing metabolic abnormalities such as dyslipidemia, hypertension, and inflammation, it is also a strong predictor of subclinical atherosclerosis progression in adults with T1D independent of these factors.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Presence of coronary artery calcium (CAC) >0 and progression of CAC by metabolic abnormity (MA) finding and weight group. P values are given for the difference among those with normal weight and obesity in MA and without MA type 1 diabetes (T1D) subjects.
See this image and copyright information in PMC

References

    1. Purnell JQ. Hokanson JE. Marcovina SM. Steffes MW. Cleary PA. Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA. 1998;280:140–146. - PMC - PubMed
    1. Kilpatrick ES. Rigby AS. Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care. 2007;30:707–712. - PubMed
    1. Pambianco G. Costacou T. Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care. 2007;30:1248–1254. - PubMed
    1. Laakso M. Pyorala K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non–insulin-dependent diabetes. Metabolism. 1990;39:117–122. - PubMed
    1. Arai K. Yokoyama H. Okuguchi F. Yamazaki K. Takagi H. Hirao K. Kobayashi M. Japan Diabetes Clinical Data Management Study Group: Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13) Endocr J. 2008;55:1025–1032. - PubMed

Publication types

MeSH terms